Does DABRAFENIB Cause Mobility decreased? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Mobility decreased have been filed in association with DABRAFENIB (Tafinlar). This represents 0.2% of all adverse event reports for DABRAFENIB.
31
Reports of Mobility decreased with DABRAFENIB
0.2%
of all DABRAFENIB reports
8
Deaths
21
Hospitalizations
How Dangerous Is Mobility decreased From DABRAFENIB?
Of the 31 reports, 8 (25.8%) resulted in death, 21 (67.7%) required hospitalization, and 3 (9.7%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which DABRAFENIB Alternatives Have Lower Mobility decreased Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB